Mouse Anti-FXYD1 (Phospho-Ser68) Recombinant Antibody (CBXF-1958) (V2LY-1225-LY340)

Cuomo, M., Florio, E., Della Monica, R., Costabile, D., Buonaiuto, M., Di Risi, T., ... & Chiariotti, L. (2022). Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues. Scientific Reports, 12(1), 6471.

Wu, D., Besnier, M., Bubb, K., Di Bartolo, B., Tang, O., & Figtree, G. (2021). FXYD1 Protects Against Pressure-Overload Cardiac Remodelling and Fibrosis. Heart, Lung and Circulation, 30, S124.

Jan, V., Miš, K., Nikolic, N., Dolinar, K., Petrič, M., Bone, A., ... & Pirkmajer, S. (2021). Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na+, K+-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells. Plos one, 16(2), e0247377.

Bubb, K. J., Tang, O., Gentile, C., Moosavi, S. M., Hansen, T., Liu, C. C., ... & Figtree, G. A. (2021). FXYD1 Is Protective Against Vascular Dysfunction. Hypertension, 77(6), 2104-2116.

Yuan, Z. F., Mao, S. S., Shen, J., Jiang, L. H., Xu, L., Xu, J. L., & Gao, F. (2020). Insulin-like growth factor-1 down-regulates the phosphorylation of FXYD1 and rescues behavioral deficits in a mouse model of Rett syndrome. Frontiers in Neuroscience, 14, 20.

Moosavi, S. M., van Reyk, D., Di Bartolo, B., Tang, O., Bubb, K. J., & Figtree, G. A. (2020). Absence of Fxyd1 is Associated With a Female-specific Pro-inflammatory and Hypercholesterolemic Environment: Implications for Atherosclerosis. Circulation, 142(Suppl_3), A16286-A16286.

O’Donnell, A. M., Nakamura, H., Tomuschat, C., Marayati, N. F., & Puri, P. (2019). Abnormal Scn1b and Fxyd1 gene expression in the pulled-through ganglionic colon may influence functional outcome in patients with Hirschsprung’s disease. Pediatric surgery international, 35, 9-14.

Matagne, V., Wondolowski, J., Frerking, M., Shahidullah, M., Delamere, N. A., Sandau, U. S., ... & Ojeda, S. R. (2018). Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice. Brain research, 1697, 45-52.

Christiansen, D., Murphy, R. M., Bangsbo, J., Stathis, C. G., & Bishop, D. J. (2018). Increased FXYD1 and PGC‐1α mRNA after blood flow‐restricted running is related to fibre type‐specific AMPK signalling and oxidative stress in human muscle. Acta physiologica, 223(2), e13045.

Bubb, K., Tang, O., Hansen, T., & Figtree, G. (2018). Oxidative modification of the cardiac sodium potassium pump is worsened in the absence of FXYD1, contributing to cardiac dysfunction and fibrosis. Free Radical Biology and Medicine, 128, S21.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols